glycopyrrolate Report issue

Small molecule Experimental
AACT ChEMBL PubChem

Active Ingredient History

NOW
  • Now
Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is given by mouth, via intravenous injection, on the skin, and via inhalation. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN) or glycopyrrolate (USAN).   Wikipedia

Chemistry

  • SMILES: [Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3
  • InChIKey: VPNYRYCIDCJBOM-UHFFFAOYSA-M
  • Mol. Mass: 398.34
  • ALogP: 2.46
  • ChEMBL Molecules:
    glycopyrrolate  
    glycopyrronium  
More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral, Parenteral, Topical
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0214 - $109.2512
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

glycopyrrolate | glycopyrrolate mixture with indacaterol | sun-101

Organizations (23)

Research & Development (23)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (27)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (27)


 

Abdominal Neoplasms (Phase 4)

Anesthesia (Phase 4)

Anesthesia and Analgesia (Phase 4)

Bronchoscopy (Phase 4)

Burns (Phase 3)

Constipation (Phase 1)

Coronary Artery Disease (Phase 4)

Delayed Emergence from Anesthesia (Phase 4)

Epilepsy (Phase 4)

Fecal Incontinence (Early Phase 1)

Fractures, Bone (Phase 4)

General Surgery (Phase 4)

Headache (Phase 4)

Hydrocephalus (Phase 4)

Laryngoscopy (Phase 4)

Neoplasm Metastasis (Phase 4)

Neoplasms (Phase 4)

Neurodevelopmental Disorders (Phase 4)

Neurofibromatoses (Phase 4)

Neurogenic Bowel (Phase 1)

Neuromuscular Blockade (Phase 4)

Pharmacokinetics (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Sialorrhea (Phase 4)

Spinal Cord Injuries (Phase 1)

Spinal Injuries (Phase 4)

Urinary Bladder Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 35
  • # of Trial Organizations: 23

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue